Larvol Delta - Blade-Therapeutics-Reaches-Enrollment-Goal-for-Phase-2-Study-of-Lead-Investigational-Therapy-BLD2660-in-Treating-Patients-With-COVID19-Pneumonia

BLD-2660 - Blade Therap

https://www.businesswire.com/news/home/20200914005091/en/Blade-Therapeutics-Reaches-Enrollment-Goal-for-Phase-2-Study-of-Lead-Investigational-Therapy-BLD-2660-in-Treating-Patients-With-COVID-19-Pneumonia

Sep 14, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next